Allocation of Bamlanivimab by Jurisdiction

Bamlanivimab is allocated by the federal government to states, territories, and federal entities on a weekly basis. Bamlanivimab Allocation Table is current as of January 19, 2020.

Distribution Weeks:

Distribution Cycle 1 - Week 1: November 9-17, 2020
Distribution Cycle 2 - Week 2: November 18-23, 2020
Distribution Cycle 3 - Week 3: November 24 - December 1, 2020
Distribution Cycle 4 - Week 4: December 2-8, 2020
Distribution Cycle 5 - Week 5: December 9-15, 2020
Distribution Cycle 6 - Week 6: December 16-22, 2020
Distribution Cycle 7 - Weeks 7-8: December 22, 2020 - January 5, 2021
Distribution Cycle 9 - Week 9-10: January 6-19, 2021
Distribution Cycle 10 - Week 11-12: January 19-February 2, 2021

States / Territories / Federal Entities	Week 1 Phase 1 (patient courses)	Week 2 Phase 1 (patient courses)	Week 3 Phase 2 (patient courses)	Week 4 Phase 2 (patient courses)	Week 5 Phase 2 (patient courses)	Week 6 Phase 2 (patient courses)	Week 7-8 Phase 2 (patient courses)	Week 9-10 Phase 2 (patient courses)	Week 11-12 Phase 2 (patient courses)	Total Patient Courses Allocated
Alabama	1,080	500	610	580	660	760	1670	1,670	5,000	12,530
Alaska	240	120	120	130	120	120	60	110	150	1,170
American Samoa	10	0	0	0	0	0	0	0	0	10
Arizona	1,250	630	970	970	1,230	1,670	2940	3,210	4,310	17,180
Arkansas	950	450	530	460	470	500	1,020	1,060	1,300	6,740
Bureau of Prisons	100	0	0	0	0	0	0	0	0	100
California	4,040	2,250	3,230	3,790	4,450	6,420	14,020	14,420	18,050	70,670
Colorado	1,980	1,080	1,320	1,130	960	960	500	480	730	9,140
Commonwealth of the Northern Mariana Islands	10	0	10	0	10	10	10	0	0	50
Connecticut	600	420	510	430	530	570	970	800	1,370	6,200
Delaware	140	90	120	140	170	190	420	290	400	2,060
Department of Defense	300	0	200	300	0	0	200	200	100	1,500
Department of Health and Human Services	0	0	100	0	0	0	0	0	0	100
Department of State	50	0	0	200	0	0	0	0	0	250
District of Columbia	90	50	60	90	70	80	150	140	220	950
Federated States of Micronesia	10	0	0	0	0	0	0	0	0	10
Florida	3,890	1,730	2,230	2,150	2,140	2,370	5,040	5,590	7,400	32,540
Georgia	1,920	860	1,010	940	1,100	1,440	3,000	3,880	4,640	18,790
Guam	50	100	50	20	10	10	10	10	30	290
Hawaii	80	30	40	60	30	30	60	60	100	490
Idaho	680	290	330	330	280	290	500	510	590	3,800
Illinois	6,380	2,930	3,160	2,340	2,080	2,080	3,730	3,310	3,320	29,330
Indiana	2,750	1,480	1,700	1,470	1,410	1,410	2,490	2,150	2,340	17,200
Indian Health Service	300	0	200	300	0	0	700	1,400	1,400	6,000
Iowa	2,110	1,030	1,030	680	510	510	670	670	800	8,010
Kansas	1,330	700	780	630	580	580	1,510	1,780	1,860	9,950
Kentucky	1,980	920	1,140	1,030	1,010	1,020	2,170	1,800	1,850	13,120
Louisiana	690	540	620	530	620	620	1,150	12,090	1,820	7,880
Maine	90	50	60	60	70	80	170	170	360	1,110
Maryland	840	520	710	700	690	690	1,210	1,180	1,560	8,100
Massachusetts	1,020	560	670	600	870	1,010	1,870	1,600	1,920	10,120
Michigan	3,240	1,740	2,090	1,970	1,580	1,580	2,810	2,710	3,080	20,800
Minnesota	2,400	1,400	1,580	1,310	990	99	1,590	1,460	2,460	14,180
Mississippi	660	330	420	410	430	510	1,770	1,760	1,910	8,600
Missouri	2,440	1,230	1,410	1,070	900	900	1,620	1,380	1,380	12,330
Montana	710	310	370	260	210	210	290	190	280	2,830
National Institute of Health	0	50	0	0	0	0	0	0	0	50
Nebraska	1,170	570	630	490	480	480	940	940	1,030	6,730
Nevada	800	470	590	600	590	630	1,140	880	1,040	6,740
New Hampshire	100	70	100	130	150	180	310	310	430	1,780
New Jersey	1,550	980	1,200	1,190	1,200	1,300	2,350	2,040	3,320	15,130
New Mexico	750	340	590	420	370	370	590	490	610	4,530
New York	2,140	1,350	1,670	1,940	2,210	2,430	5,190	5,660	8,350	30,940
North Carolina	1,690	740	970	930	1,030	1,270	2,520	2,490	4,040	15,680
North Dakota	770	290	320	200	180	190	150	110	130	2,340
Ohio	3,420	1,900	2,330	2,330	2,150	2,690	4,930	4,130	4,160	28,040
Oklahoma	1,230	770	940	910	770	790	1,650	1,630	1,910	10,600
Oregon	430	230	300	340	300	300	520	420	630	3,470
Palau	10	0	0	0	0	0	0	0	0	10
Pennsylvania	2,300	1,380	1,870	1,980	1,280	2,490	5,120	4,920	4,920	27,660
Puerto Rico	640	180	200	170	150	150	340	200	390	2,240
Republic of Marshall Islands	10	0	0	0	0	0	0	0	0	10
Rhode Island	310	160	210	190	220	220	370	330	540	2,550
South Carolina	800	360	410	390	510	600	1,300	1,560	2,300	8,230
South Dakota	820	340	340	240	230	230	460	430	460	3,550
Tennessee	1,900	1,080	1,170	1,130	1,100	1,560	3,450	2,480	2,500	16,370
Texas	5,780	3,190	3,840	3,260	3,160	3,590	8,130	8,590	12,660	53,415
U.S. Virgin Islands	10	10	10	10	10	10	10	10	20	100
Utah	1,300	600	750	510	540	540	890	760	900	6,790
Vermont	20	20	30	20	30	40	100	40	100	400
Veterans Health Administration	300	0	200	300	0	0	200	200	200	1,400
Virginia	1,010	430	620	640	650	820	1,570	1,750	3,170	10,660
Washington	720	410	430	570	510	530	720	770	1,480	6,140
West Virginia	370	100	260	270	260	280	580	510	800	3,430
Wisconsin	4,260	1,860	1,990	1,380	1,110	1,110	2,190	1,970	1,970	17,840
Wyoming	330	160	200	140	110	110	160	110	220	1,540
All Jurisdictions (patient courses)	79,350	40,380	49,550	45,760	44,380	50,520	100,900	99,010	129,010	642,675

Total Monoclonal Antibody Therapeutics Allocated as of January 19, 2021 and Delivered as of January 19, 2021

Therapeutic	Total Allocation (patient courses)	Total Delivered (patient courses)
Bamlanivimab	642,675	454,087
Casirivimab/imdevimab	142,978	96,923
All Monoclonal Antibody Therapeutics	785,653	551,010

Allocation Phases

Phase 1: allocation to hospitals and hospital-affiliated locations
Phase 2: allocation expanded to additional outpatients facilities

HHS-ASPR Resources

This page last reviewed: January 19, 2021